✦ LIBER ✦

Does Pre-treatment Metabolic Tumor Growth Rate (MTGR) Predict Progression in Lung Cancer?

✍ Scribed by D.V. Eastham; C.H. Chapman; A.K. Rao; B. Narasimhan; A. Quon; M.S. Vasanawala; H. Wakelee; Q. Le; A.D. Colevas; B.W. Loo

Book ID: 108148919
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 41 KB
Volume: 75
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2009.07.1020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Does pre-treatment plasma transforming g

Does pre-treatment plasma transforming growth factor beta (TGF-β1) level predict outcome in breast cancer patients following radiotherapy?

✍ R.G Prosnitz; M.S Anscher; H Huang; R Clough; R.L Jirtle; L.B Marks 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Pre-treatment Lung Density Does Not Pred

Pre-treatment Lung Density Does Not Predict For Pulmonary Toxicity in Patients Treated With Stereotactic Body Radiation Therapy (SBRT) for Early-stage Non-small Cell Lung Cancer (NSCLC)

✍ Crandley, E.F.; Dunlap, N.; Larner, J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 37 KB

High rates of tumor growth and disease p

High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer

✍ Sarah Everitt; Alan Herschtal; Jason Callahan; Nikki Plumridge; David Ball; Toma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB 👁 1 views

## Abstract ## BACKGROUND: The authors studied growth and progression of untreated nonsmall cell lung cancer (NSCLC) by comparing diagnostic and radiotherapy (RT) planning fluorodeoxyglucose (FDG)‐positron emission tomography (PET)/computed tomography (CT) scans before proposed radical chemo‐RT.